Form 4: Organon CFO Matthew Walsh Reports Equity Transactions

Organon & Co. CFO Matthew Walsh reported the vesting of restricted stock units and the grant of new equity awards in a recent SEC Form 4 filing.

Summary

• CFO Matthew Walsh acquired 33,593 shares of common stock through the vesting of restricted stock units (RSUs) on March 31, 2026.
• A total of 11,507 shares were withheld by the company to satisfy tax obligations at a price of $5.70 per share.
• The reporting person was granted 404,840 new RSUs, which are scheduled to vest in three equal annual installments starting March 31, 2027.
• Following these transactions, the reporting person holds 212,746 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding executive compensation and ownership changes.

Positives

• The CFO maintains a significant direct ownership stake of 212,746 shares, aligning interests with shareholders.
• The issuance of new RSUs serves as a long-term retention incentive for key executive leadership.

Negatives

• The company withheld 11,507 shares to cover tax liabilities associated with the vesting of equity awards.

Risks

• Future share price volatility could impact the ultimate value of the newly granted 404,840 RSUs.
• The vesting of equity is subject to continued employment and potential performance conditions inherent in the company's incentive plans.

Future Outlook

The newly granted RSUs are set to vest in three equal installments on March 31, 2027, March 31, 2028, and March 31, 2029, contingent upon continued service.

Industry Context

StockSavvy.ai notes that executive equity transactions are standard corporate governance practices, reflecting routine compensation cycles rather than shifts in strategic direction or market outlook.

Comparison to Industry Standards

• The use of multi-year vesting schedules for RSUs is consistent with standard executive compensation practices in the pharmaceutical and biotech sectors.
• Tax withholding upon vesting is a standard administrative procedure for equity-based compensation.

Stakeholder Impact

• Shareholders should note the dilution impact of the new RSU grants, though these are typical for executive retention.

Next Steps

• Vesting of the first installment of the new RSU grants on March 31, 2027.

Key Dates

Keywords

Organon, OGN, CFO, Insider Trading, Form 4, Equity Compensation, Restricted Stock Units